Sleeping sickness drug may provide long-term protection against nonmelanoma skin cancers

An antiparasitic agent used to treat African sleeping sickness might someday be used to prevent nonmelanoma skin cancers. Researchers found that DFMO, or alpha-difluoromethylornithine, still appeared to protect against nonmelanoma skin cancers years after people stopped taking the drug, according to new research.

Read the whole article on Science Daily

More from Science Daily